Product NDC: | 21695-357 |
Proprietary Name: | Exelon |
Non Proprietary Name: | rivastigmine |
Active Ingredient(s): | 4.6 mg/24[USP'U] & nbsp; rivastigmine |
Administration Route(s): | TRANSDERMAL |
Dosage Form(s): | PATCH, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 21695-357 |
Labeler Name: | Rebel Distributors Corp |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA022083 |
Marketing Category: | NDA |
Start Marketing Date: | 20091007 |
Package NDC: | 21695-357-30 |
Package Description: | 30 PATCH in 1 CARTON (21695-357-30) > 24 [USP'U] in 1 PATCH |
NDC Code | 21695-357-30 |
Proprietary Name | Exelon |
Package Description | 30 PATCH in 1 CARTON (21695-357-30) > 24 [USP'U] in 1 PATCH |
Product NDC | 21695-357 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | rivastigmine |
Dosage Form Name | PATCH, EXTENDED RELEASE |
Route Name | TRANSDERMAL |
Start Marketing Date | 20091007 |
Marketing Category Name | NDA |
Labeler Name | Rebel Distributors Corp |
Substance Name | RIVASTIGMINE |
Strength Number | 4.6 |
Strength Unit | mg/24[USP'U] |
Pharmaceutical Classes | Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |